_version_ 1784639884610240512
author He, Rong
Chiou, Jonathan
Chiou, Allison
Chen, Dong
Chen, Constance P.
Spethman, Caroline
Bessonen, Kurt R.
Oliveira, Jennifer L.
Nguyen, Phuong L.
Reichard, Kaaren K.
Hoyer, James D.
Althoff, Simon D.
Roh, Dana J.
Miller, Mechelle A.
Yuan, Ji
Olteanu, Horatiu
Begna, Kebede
Tefferi, Ayalew
Alkhateeb, Hassan
Patnaik, Mrinal M.
Litzow, Mark R.
Al-Kali, Aref
Viswanatha, David S.
author_facet He, Rong
Chiou, Jonathan
Chiou, Allison
Chen, Dong
Chen, Constance P.
Spethman, Caroline
Bessonen, Kurt R.
Oliveira, Jennifer L.
Nguyen, Phuong L.
Reichard, Kaaren K.
Hoyer, James D.
Althoff, Simon D.
Roh, Dana J.
Miller, Mechelle A.
Yuan, Ji
Olteanu, Horatiu
Begna, Kebede
Tefferi, Ayalew
Alkhateeb, Hassan
Patnaik, Mrinal M.
Litzow, Mark R.
Al-Kali, Aref
Viswanatha, David S.
author_sort He, Rong
collection PubMed
description
format Online
Article
Text
id pubmed-8789920
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-87899202022-02-07 Molecular markers demonstrate diagnostic and prognostic value in the evaluation of myelodysplastic syndromes in cytopenia patients He, Rong Chiou, Jonathan Chiou, Allison Chen, Dong Chen, Constance P. Spethman, Caroline Bessonen, Kurt R. Oliveira, Jennifer L. Nguyen, Phuong L. Reichard, Kaaren K. Hoyer, James D. Althoff, Simon D. Roh, Dana J. Miller, Mechelle A. Yuan, Ji Olteanu, Horatiu Begna, Kebede Tefferi, Ayalew Alkhateeb, Hassan Patnaik, Mrinal M. Litzow, Mark R. Al-Kali, Aref Viswanatha, David S. Blood Cancer J Correspondence Nature Publishing Group UK 2022-01-25 /pmc/articles/PMC8789920/ /pubmed/35078969 http://dx.doi.org/10.1038/s41408-022-00612-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correspondence
He, Rong
Chiou, Jonathan
Chiou, Allison
Chen, Dong
Chen, Constance P.
Spethman, Caroline
Bessonen, Kurt R.
Oliveira, Jennifer L.
Nguyen, Phuong L.
Reichard, Kaaren K.
Hoyer, James D.
Althoff, Simon D.
Roh, Dana J.
Miller, Mechelle A.
Yuan, Ji
Olteanu, Horatiu
Begna, Kebede
Tefferi, Ayalew
Alkhateeb, Hassan
Patnaik, Mrinal M.
Litzow, Mark R.
Al-Kali, Aref
Viswanatha, David S.
Molecular markers demonstrate diagnostic and prognostic value in the evaluation of myelodysplastic syndromes in cytopenia patients
title Molecular markers demonstrate diagnostic and prognostic value in the evaluation of myelodysplastic syndromes in cytopenia patients
title_full Molecular markers demonstrate diagnostic and prognostic value in the evaluation of myelodysplastic syndromes in cytopenia patients
title_fullStr Molecular markers demonstrate diagnostic and prognostic value in the evaluation of myelodysplastic syndromes in cytopenia patients
title_full_unstemmed Molecular markers demonstrate diagnostic and prognostic value in the evaluation of myelodysplastic syndromes in cytopenia patients
title_short Molecular markers demonstrate diagnostic and prognostic value in the evaluation of myelodysplastic syndromes in cytopenia patients
title_sort molecular markers demonstrate diagnostic and prognostic value in the evaluation of myelodysplastic syndromes in cytopenia patients
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789920/
https://www.ncbi.nlm.nih.gov/pubmed/35078969
http://dx.doi.org/10.1038/s41408-022-00612-w
work_keys_str_mv AT herong molecularmarkersdemonstratediagnosticandprognosticvalueintheevaluationofmyelodysplasticsyndromesincytopeniapatients
AT chioujonathan molecularmarkersdemonstratediagnosticandprognosticvalueintheevaluationofmyelodysplasticsyndromesincytopeniapatients
AT chiouallison molecularmarkersdemonstratediagnosticandprognosticvalueintheevaluationofmyelodysplasticsyndromesincytopeniapatients
AT chendong molecularmarkersdemonstratediagnosticandprognosticvalueintheevaluationofmyelodysplasticsyndromesincytopeniapatients
AT chenconstancep molecularmarkersdemonstratediagnosticandprognosticvalueintheevaluationofmyelodysplasticsyndromesincytopeniapatients
AT spethmancaroline molecularmarkersdemonstratediagnosticandprognosticvalueintheevaluationofmyelodysplasticsyndromesincytopeniapatients
AT bessonenkurtr molecularmarkersdemonstratediagnosticandprognosticvalueintheevaluationofmyelodysplasticsyndromesincytopeniapatients
AT oliveirajenniferl molecularmarkersdemonstratediagnosticandprognosticvalueintheevaluationofmyelodysplasticsyndromesincytopeniapatients
AT nguyenphuongl molecularmarkersdemonstratediagnosticandprognosticvalueintheevaluationofmyelodysplasticsyndromesincytopeniapatients
AT reichardkaarenk molecularmarkersdemonstratediagnosticandprognosticvalueintheevaluationofmyelodysplasticsyndromesincytopeniapatients
AT hoyerjamesd molecularmarkersdemonstratediagnosticandprognosticvalueintheevaluationofmyelodysplasticsyndromesincytopeniapatients
AT althoffsimond molecularmarkersdemonstratediagnosticandprognosticvalueintheevaluationofmyelodysplasticsyndromesincytopeniapatients
AT rohdanaj molecularmarkersdemonstratediagnosticandprognosticvalueintheevaluationofmyelodysplasticsyndromesincytopeniapatients
AT millermechellea molecularmarkersdemonstratediagnosticandprognosticvalueintheevaluationofmyelodysplasticsyndromesincytopeniapatients
AT yuanji molecularmarkersdemonstratediagnosticandprognosticvalueintheevaluationofmyelodysplasticsyndromesincytopeniapatients
AT olteanuhoratiu molecularmarkersdemonstratediagnosticandprognosticvalueintheevaluationofmyelodysplasticsyndromesincytopeniapatients
AT begnakebede molecularmarkersdemonstratediagnosticandprognosticvalueintheevaluationofmyelodysplasticsyndromesincytopeniapatients
AT tefferiayalew molecularmarkersdemonstratediagnosticandprognosticvalueintheevaluationofmyelodysplasticsyndromesincytopeniapatients
AT alkhateebhassan molecularmarkersdemonstratediagnosticandprognosticvalueintheevaluationofmyelodysplasticsyndromesincytopeniapatients
AT patnaikmrinalm molecularmarkersdemonstratediagnosticandprognosticvalueintheevaluationofmyelodysplasticsyndromesincytopeniapatients
AT litzowmarkr molecularmarkersdemonstratediagnosticandprognosticvalueintheevaluationofmyelodysplasticsyndromesincytopeniapatients
AT alkaliaref molecularmarkersdemonstratediagnosticandprognosticvalueintheevaluationofmyelodysplasticsyndromesincytopeniapatients
AT viswanathadavids molecularmarkersdemonstratediagnosticandprognosticvalueintheevaluationofmyelodysplasticsyndromesincytopeniapatients